The White House prepares a decree on the production of certain drugs only in the United States

The White House is preparing a decree on the production of certain drugs in the United States only. About it, how it transmits Trend compared to TASSCNBC reported Thursday.

Sources say the decree could be signed on Friday by the President of the United States, Donald Trump. The Trump administration is developing a system to guarantee the supply of a range of goods that affect the national security of the country. The list of these products includes drugs, semiconductors and military equipment.

About 72% of the composition of pharmaceuticals sold in the United States is produced in other countries, including China. The White House is adamantly against this situation and considers that it is necessary to produce certain categories of drugs in the United States, so that in the event of an emergency, such as for the coronavirus pandemic, it will not not depend on other countries.

A senior official from the Washington administration during a conference call for journalists on Thursday announced a decision to modernize the strategic supply of medical supplies, which has been virtually unaffordable since 2009. In the strategic reserve , they are just over a quarter of the funds needed to fight the new coronavirus p andemic. The administration has promised within 90 days to create a reserve necessary to fight the pandemic.

According to Johns Hopkins University, whose federal and local authorities estimate that there have been more than 1.41 million cases of coronavirus infection in the United States, with 85,884 people dead.